Transamerica Financial Advisors Inc. Purchases Shares of 306 The Allstate Co. (NYSE:ALL)

Transamerica Financial Advisors Inc. purchased a new stake in The Allstate Co. (NYSE:ALL) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 306 shares of the insurance provider’s stock, valued at approximately $58,000.

A number of other hedge funds also recently made changes to their positions in ALL. B. Riley Wealth Advisors Inc. boosted its holdings in shares of Allstate by 28.4% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 3,945 shares of the insurance provider’s stock valued at $683,000 after purchasing an additional 873 shares during the last quarter. Tidal Investments LLC boosted its holdings in shares of Allstate by 35.4% in the 1st quarter. Tidal Investments LLC now owns 27,999 shares of the insurance provider’s stock valued at $4,844,000 after purchasing an additional 7,324 shares during the last quarter. Plato Investment Management Ltd boosted its holdings in shares of Allstate by 787.9% in the 1st quarter. Plato Investment Management Ltd now owns 1,101 shares of the insurance provider’s stock valued at $190,000 after purchasing an additional 977 shares during the last quarter. Strategic Wealth Partners Ltd. acquired a new position in shares of Allstate in the 1st quarter valued at $260,000. Finally, Swedbank AB acquired a new position in shares of Allstate in the 1st quarter valued at $5,480,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Insider Transactions at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.80% of the company’s stock.

Allstate Price Performance

ALL opened at $208.19 on Thursday. The company has a 50-day moving average of $192.34 and a 200-day moving average of $178.57. The company has a market capitalization of $55.13 billion, a P/E ratio of 13.48, a PEG ratio of 1.80 and a beta of 0.48. The Allstate Co. has a 1-year low of $134.17 and a 1-year high of $209.88. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping the consensus estimate of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s revenue was up 14.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.81 EPS. Equities analysts expect that The Allstate Co. will post 16.07 EPS for the current fiscal year.

Allstate Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 1.77%. The ex-dividend date is Friday, November 29th. Allstate’s payout ratio is currently 23.83%.

Analyst Ratings Changes

Several equities analysts recently weighed in on ALL shares. TD Cowen lifted their target price on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Wells Fargo & Company lifted their target price on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. UBS Group lifted their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Keefe, Bruyette & Woods lifted their target price on shares of Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a report on Wednesday, November 6th. Finally, Jefferies Financial Group lifted their target price on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $217.19.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.